Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ascendis Pharma A/S (ASND) vs Dover Corp (DOV) Price & Performance

Ascendis Pharma A/STrade
Dover CorpTrade

Price performance (Past 24H)

Key statistics

Ascendis Pharma A/S vs Dover Corp — how do they compare? Ascendis Pharma A/S trades at $254.5 (market cap $16.67B), while Dover Corp trades at $208.79 (market cap $28.07B). The key difference: Dover Corp is the larger of the two by market cap, and Dover Corp pays a 1.01% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.

ASNDDOV
Market Cap
$16.67B$28.07B
Sector
HealthIndustrials
52-Week High
$277.18$233.31
52-Week Low
$189.74$161.16
Enterprise Value
$17.04B$29.58B
Dividend Yield
1.01%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.

Read more on ASND

About Dover Corp

Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.

Read more on DOV